Top bar
About POGO's Federal Contractor Misconduct Database (FCMD)
The government awards contracts to companies with histories of misconduct such as contract fraud and environmental, ethics, and labor violations. In the absence of a centralized federal database listing instances of misconduct, the Project On Government Oversight (POGO) is providing such data. We believe that it will lead to improved contracting decisions and public access to information about how the government spends hundreds of billions of taxpayer money each year on goods and services. Report an instance of misconduct »
GlaxoSmithKline
South Korea Antitrust Fine
Date: 10/27/2011
Misconduct Type: Antitrust
Enforcement Agency: International
Contracting Party: None
Court Type: N/A
Amount: $2,651,737
Disposition: Fine
Synopsis: South Korea’s Fair Trade Commission fined GlaxoSmithKline three billion won (approx. US$2.6 million) for conspiring with a Seoul rival over the sale of drugs. According to the South Korean government, Glaxo in 2000 offered Dong-A Pharmaceutical the exclusive right to sell its anti-nausea drug Zofran and an anti-viral medication called Valtrex; in return, Glaxo demanded that Dong-A stop selling a cheaper generic version of Zofran and not produce or sell any drugs that could compete against Zofran and Valtrex.
Document(s):
Sorry, no documents were found with that case id.
Quick Search
= link